<DOC>
	<DOCNO>NCT02153879</DOCNO>
	<brief_summary>The structural functional alteration high density lipoprotein ( HDL ) level type 2 diabetes ( T2D ) patient link hypertriglyceridemia , hyperglycemia , insulin resistance , inflammation oxidation , play major role increase macrovascular risk patient . An impaired function adipose tissue ( AT ) T2D contribute low HDL concentration . Objectives : 1 ) Quantitative qualitative characterisation HDL subclasses ultracentrifugation , proteomic metabolomic technique . 2 ) To study relationship HDL subclasses , preβ1 HDL remnant HDL , clinical determinant arteriosclerosis . 3 ) Functional vitro study HDL subclass determine Objective 1 . 4 ) To study role AT determine low HDL level . 5 ) To study impact HDL increase drug HDL qualitative change .</brief_summary>
	<brief_title>Characterization High Density Lipoprotein ( HDL ) Type 2 Diabetes ( T2D ) After Fenofibrate Niacin Treatment</brief_title>
	<detailed_description>Groups subject : ) Diabetic patient low HDL ; b ) Non-diabetic patient low HDL ; c ) Diabetic patient normal HDL level ; ) Non-diabetic patient normal HDL level . The study perform wash lipid lower drug . Intima medium thickness ( IMT ) perform group . Main biochemical technique centralise . Isolation characterisation HDL subclasses remnant HDL , well determination preβ1 HDL perform . HDL study examine HDL proteomic metabolomic profile perform . Functional study determine effect endothelium , inflammation , cholesterol efflux oxidation accord qualitative change . These HDL measurement repeat group ( ) , treat fibrates Niacin . HDL metabolism adipocytes extensively study , clinical association HDL alteration plasma AT-derived molecule examine .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Type 2 diabetic patient Age 30 year 70 year HDL exceed 50 mg/dl men 60 mg/dl woman smoker To diagnose diabetes less three month To triglyceride level 400 mg/dl Glycated hemoglobin high 9 % Albuminuria 300 mg/mg creatinine Chronic kidney disease ( eFGR &lt; 30 ml/min/1.73 m2 ) Advanced retinopathy Neuropathy Cardiovascular disease last three month Chronic liver insufficiency Neoplastic disease chronic incapacitate disease</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>HDL</keyword>
	<keyword>Niacin</keyword>
	<keyword>Fenofibrate</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Metabolomics</keyword>
</DOC>